for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Psychemedics Corp.

PMD.OQ

Latest Trade

9.42USD

Change

0.59(+6.68%)

Volume

28,568

Today's Range

8.83

 - 

9.52

52 Week Range

7.18

 - 

19.59

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
8.83
Open
8.83
Volume
28,568
3M AVG Volume
0.46
Today's High
9.52
Today's Low
8.83
52 Week High
19.59
52 Week Low
7.18
Shares Out (MIL)
5.52
Market Cap (MIL)
51.97
Forward P/E
--
Dividend (Yield %)
7.64

Latest Developments

More

Psychemedics Corp Announces New Brazilian Distribution Agreement

Psychemedics Q2 Earnings Per Share $0.14

Psychemedics Q1 Earnings Per Share $0.11

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Psychemedics Corp.

Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.

Industry

Healthcare Facilities

Contact Info

125 Nagog Park Ste 200

+1.800.6288073

https://www.psychemedics.com/

Executive Leadership

Raymond C. Kubacki

Chairman of the Board, President, Chief Executive Officer

Charles Doucot

Executive Vice President

Neil L. Lerner

Vice President - Finance

Michael I. Schaffer

Vice President - Laboratory Operations

A. Clinton Allen

Independent Director

Key Stats

Price To Earnings (TTM)
14.69
Price To Sales (TTM)
1.30
Price To Book (MRQ)
2.81
Price To Cash Flow (TTM)
7.89
Total Debt To Equity (MRQ)
7.69
LT Debt To Equity (MRQ)
5.44
Return on Investment (TTM)
16.80
Return on Equity (TTM)
13.77

Latest News

BRIEF-Psychemedics Corp Q1 Earnings Per Share $0.23

* PSYCHEMEDICS ANNOUNCES 1Q RECORD REVENUES AND DIVIDEND INCREASE OF 20%

BRIEF-Psychemedics Corporation Q4 Earnings Per Share $0.42

* Q4 REVENUE FELL 9 PERCENT TO $9.8 MILLION Source text for Eikon: Further company coverage:

BRIEF-Psychemedics Corp reports Q3 earnings per share $0.25

* Q3 revenue fell 15 percent to $10 million Source text for Eikon: Further company coverage:

BRIEF-Psychemedics Q2 earnings per share $0.16

* Q2 revenue $9.7 million versus $9.7 million Source text for Eikon: Further company coverage:

BRIEF-Psychemedics Corp reports Q1 earnings per share $0.27

* Psychemedics Corporation announces record q1 revenues and earnings

BRIEF-Psychemedics Corporation announces record revenues and earnings

* Psychemedics Corporation announces record revenues and earnings

BRIEF-Psychemedics Corp quarterly earnings per share $0.49

* Psychemedics Corporation announces record revenues and earnings

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up